Cargando…

Emerging Targets for Developing T Cell-Mediated Vaccines for Human Immunodeficiency Virus (HIV)-1

Human immunodeficiency virus (HIV)-1 has infected >75 million individuals globally, and, according to the UN, is responsible for ~2.1 million new infections and 1.1 million deaths each year. Currently, there are ~37 million individuals with HIV infection and the epidemic has already resulted in 3...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wijesundara, Danushka K., Ranasinghe, Charani, Grubor-Bauk, Branka, Gowans, Eric J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5660999/ https://www.ncbi.nlm.nih.gov/pubmed/29118747 http://dx.doi.org/10.3389/fmicb.2017.02091

Ejemplares similares

Toward DNA-Based T-Cell Mediated Vaccines to Target HIV-1 and Hepatitis C Virus: Approaches to Elicit Localized Immunity for Protection
por: Mekonnen, Zelalem A., et al.
Publicado: (2019)

Preclinical Development and Production of Virus-Like Particles As Vaccine Candidates for Hepatitis C
por: Masavuli, Makutiro Ghislain, et al.
Publicado: (2017)

Mucosal vaccination with a live recombinant rhinovirus followed by intradermal DNA administration elicits potent and protective HIV-specific immune responses
por: Tomusange, Khamis, et al.
Publicado: (2016)

A HIV-Tat/C4-binding protein chimera encoded by a DNA vaccine is highly immunogenic and contains acute EcoHIV infection in mice
por: Tomusange, Khamis, et al.
Publicado: (2016)

Cytolytic Perforin as an Adjuvant to Enhance the Immunogenicity of DNA Vaccines
por: Shrestha, Ashish C., et al.
Publicado: (2019)

A Hepatitis C Virus DNA Vaccine Encoding a Secreted, Oligomerized Form of Envelope Proteins Is Highly Immunogenic and Elicits Neutralizing Antibodies in Vaccinated Mice
por: Masavuli, Makutiro Ghislain, et al.
Publicado: (2019)

Safety Profile of a Multi-Antigenic DNA Vaccine Against Hepatitis C Virus
por: Gummow, Jason, et al.
Publicado: (2020)

Hepatitis C virus drives the pathogenesis of hepatocellular carcinoma: from immune evasion to carcinogenesis
por: Canavese, Miriam, et al.
Publicado: (2016)

Cytolytic DNA vaccine encoding lytic perforin augments the maturation of- and antigen presentation by- dendritic cells in a time-dependent manner
por: Wijesundara, Danushka K., et al.
Publicado: (2017)

Immunological Memory in Imiquimod-Induced Murine Model of Psoriasiform Dermatitis
por: Fenix, Kevin, et al.
Publicado: (2020)

Unraveling the Convoluted Biological Roles of Type I Interferons in Infection and Immunity: A Way Forward for Therapeutics and Vaccine Design
por: Wijesundara, Danushka Kumara, et al.
Publicado: (2014)

Enhanced T Cell Responses Induced by a Necrotic Dendritic Cell Vaccine, Expressing HCV NS3
por: Mekonnen, Zelalem A., et al.
Publicado: (2020)

Superior efficacy of a skin-applied microprojection device for delivering a novel Zika DNA vaccine
por: Wijesundara, Danushka K., et al.
Publicado: (2023)

Increase in DNA vaccine efficacy by virosome delivery and co-expression of a cytolytic protein
por: Gargett, Tessa, et al.
Publicado: (2014)

Reduced Interleukin-4 Receptor α Expression on CD8(+) T Cells Correlates with Higher Quality Anti-Viral Immunity
por: Wijesundara, Danushka K., et al.
Publicado: (2013)

Use of an In Vivo FTA Assay to Assess the Magnitude, Functional Avidity and Epitope Variant Cross-Reactivity of T Cell Responses Following HIV-1 Recombinant Poxvirus Vaccination
por: Wijesundara, Danushka K., et al.
Publicado: (2014)

Pre-clinical evaluation of a quadrivalent HCV VLP vaccine in pigs following microneedle delivery
por: Christiansen, D., et al.
Publicado: (2019)

Adjuvant Selection for Influenza and RSV Prefusion Subunit Vaccines
por: Isaacs, Ariel, et al.
Publicado: (2021)

NS1 DNA vaccination protects against Zika infection through T cell–mediated immunity in immunocompetent mice
por: Grubor-Bauk, B., et al.
Publicado: (2019)

Impact of Pre-Existing Immunity to Influenza on Live-Attenuated Influenza Vaccine (LAIV) Immunogenicity
por: Roy, Sreeja, et al.
Publicado: (2020)

Screening of Human Immunodeficiency Virus (HIV) among Newly Diagnosed Tuberculosis Patients in Eastern Sudan
por: AHMED MUSTAFA, GADA MUSTAFA, et al.
Publicado: (2021)

The Influence of Immunization Route, Tissue Microenvironment, and Cytokine Cell Milieu on HIV-Specific CD8(+) T Cells Measured Using Fluidigm Dynamic Arrays
por: Trivedi, Shubhanshi, et al.
Publicado: (2015)

Rapamycin and inulin for booster vaccine response stimulation (RIVASTIM)—rapamycin: study protocol for a randomised, controlled trial of immunosuppression modification with rapamycin to improve SARS-CoV-2 vaccine response in kidney transplant recipients
por: Tunbridge, Matthew, et al.
Publicado: (2022)

LUNG group 2 innate lymphoid cells as a new adjuvant target to enhance intranasal vaccine efficacy against influenza
por: Williams, Clare M, et al.
Publicado: (2022)

Recombinant fowlpox virus vector-based vaccines: expression kinetics, dissemination and safety profile following intranasal delivery
por: Townsend, David G, et al.
Publicado: (2017)

Electrostatic Potential of Human Immunodeficiency Virus Type 2 and Rhesus Macaque Simian Immunodeficiency Virus Capsid Proteins
por: Bozek, Katarzyna, et al.
Publicado: (2012)

Immunological responses following administration of a genotype 1a/1b/2/3a quadrivalent HCV VLP vaccine
por: Christiansen, D., et al.
Publicado: (2018)

Impact of Pre-Existing Immunity on Live Attenuated Influenza Vaccine-Induced Cross-Protective Immunity
por: Roy, Sreeja, et al.
Publicado: (2020)

Fear of Influenza Resurgence amid COVID-19 Pandemic: Need for Effective Flu Vaccine Still Exists
por: Wijesundara, Danushka K., et al.
Publicado: (2021)

Profile of the Lower Respiratory Tract Microbiome in Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome and Lung Disease
por: Chen, Zhen, et al.
Publicado: (2022)

Molecular Epidemiology and Antifungal Resistance of Cryptococcus neoformans From Human Immunodeficiency Virus-Negative and Human Immunodeficiency Virus-Positive Patients in Eastern China
por: Zhou, Ziyi, et al.
Publicado: (2022)

Insights Into the Coinfections of Human Immunodeficiency Virus-Hepatitis B Virus, Human Immunodeficiency Virus-Hepatitis C Virus, and Hepatitis B Virus-Hepatitis C Virus: Prevalence, Risk Factors, Pathogenesis, Diagnosis, and Treatment
por: Shahriar, Sagarika, et al.
Publicado: (2022)

Human immunodeficiency virus-1 core: The Trojan horse in virus–host interaction
por: Wang, Wei, et al.
Publicado: (2022)

Corrigendum: Insights into the coinfections of human immunodeficiency virus-hepatitis B virus, human immunodeficiency virus-hepatitis C virus, and hepatitis B virus-hepatitis C virus: prevalence, risk factors, pathogenesis, diagnosis, and treatment
por: Shahriar, Sagarika, et al.
Publicado: (2023)

Human Immunodeficiency Virus-1 (HIV-1)-Mediated Apoptosis: New Therapeutic Targets
por: Mbita, Zukile, et al.
Publicado: (2014)

Rhabdo-immunodeficiency virus, a murine model of acute HIV-1 infection
por: Liberatore, Rachel A, et al.
Publicado: (2019)

IL-13Rα2 Regulates the IL-13/IFN-γ Balance during Innate Lymphoid Cell and Dendritic Cell Responses to Pox Viral Vector-Based Vaccination
por: Li, Zheyi, et al.
Publicado: (2021)

Vaccination route can significantly alter the innate lymphoid cell subsets: a feedback between IL-13 and IFN-γ
por: Li, Zheyi, et al.
Publicado: (2018)

Interleukin-13 as a target to alleviate severe coronavirus disease 2019 and restore lung homeostasis
por: Deimel, Lachlan Paul, et al.
Publicado: (2021)

Virus-Like Particles: Revolutionary Platforms for Developing Vaccines Against Emerging Infectious Diseases
por: Tariq, Hasnat, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5lbn3gjknalqb7jv7h45bvrvrm